In 2005 Eli Lilly Conveniently Left Out Information that Patients on Prozac are 12x More Likely to Commit Suicide

An internal document purportedly from Eli Lilly and Co. made public Monday appears to show that the drug maker had data more than 15 years ago showing that patients on its antidepressant Prozac were far more likely to attempt suicide and show hostility than were patients on other antidepressants and that the company attempted to minimize public awareness of the side effects.